What this trial could tell us If results are positive, we would expect to see statistically significant differences between the resM group and placebo group in body weight, BMI, and relevant biomarkers like fasting glucose, insulin, and possibly GLP-1 levels
You might find yourself thinking about food more often or needing larger portions to feel full
Sugary flavoring helps make the sticky-sweet taste of cough syrup more palatable
in fact, they often reflect the medication's appetite-suppressing action, which supports both blood sugar control and weight loss
Ozempic is approved for managing diabetes, while Wegovy (semaglutide GLP-1) is tailored for weight loss, with a higher dose typically prescribed for individuals struggling with obesity